HighVista Strategies’s Bausch Health BHC Stock Holding History

HighVista Strategies’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-217,600	Closed	-$2.03M	–	151
2025 Q1	$2.03M	Buy	+217,600	New	+$1.56M	0.78%	35
2023 Q3	–	Sell	-98,351	Closed	-$787K	–	140
2023 Q2	$787K	Buy	+98,351	New	+$725K	0.36%	69
2016 Q1	–	Sell	-12,183	Closed	-$1.24M	–	171
2015 Q4	$1.24M	Buy	+12,183	New	+$1.37M	0.23%	126
2014 Q4	–	Sell	-42,726	Closed	-$5.61M	–	153
2014 Q3	$5.61M	Buy	42,726 +4,245	+11%	+$506K	0.76%	22
2014 Q2	$4.85M	Buy	38,481 +2,538	+7%	+$324K	0.69%	64
2014 Q1	$4.71M	Buy	35,943 +28,703	+396%	+$3.92M	0.63%	58
2013 Q4	$850K	Buy	+7,240	New	+$793K	0.15%	79

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

HighVista Strategies's BHC Position: Q2 2025 in Review

HighVista Strategies sold out of Bausch Health (BHC) in Q2 2025, closing a stake of 217,600 shares — an estimated $2.03M sold.

HighVista Strategies first reported a position in BHC in Q4 2013 and held it in 7 quarters. The position peaked at $5.61M in Q3 2014. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.

HighVista Strategies reported no remaining Bausch Health position as of Q2 2025 after selling out during the quarter.
HighVista Strategies sold 217,600 Bausch Health shares in Q2 2025, an estimated $2.03M.
HighVista Strategies first reported a position in Bausch Health in Q4 2013 and held it in 7 quarters.
HighVista Strategies's Bausch Health position peaked at $5.61M in Q3 2014.
212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.

Based on HighVista Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.